DRNA

Biotech Stocks List | Stock Pursuit

A lot of markets are at crucial areas here. The US major indices are probably going to decide which direction longer term they want to go. They could continue range bound for awhile longer though unless the Patriots get a hold of the air in the futures markets. They are at the top of the trading range here. You can […]

Dicerna to Announce First Quarter 2014 Financial Results and Host Conference Call on May 13, 2014

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, will report its first quarter 2014 financial results on May 13, 2014. Dicerna will host a conference call and live audio webcast on May 13, 2014, at moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who […]

Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, today announced that it granted stock options to Pankaj Bhargava, M.D., the Company’s chief medical officer, on April 16, 2014, including a stock op moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring […]

Tech correction clouds IPO prospects

[at Financial Times] – Now you see it, now you don’t. The recent boom and sudden gloom for dozens of newly listed US technology companies is perfectly illustrated by the case of Dicerna Pharmaceuticals . Three months ago the … moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is […]

3 Horrendous Health-Care Stocks This Week

moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring next, click here to view […]

Dicerna to Announce Fourth Quarter 2013 Financial Results and Host Conference Call on March 27, 2014

[at noodls] – WATERTOWN, Mass.–(BUSINESS WIRE)– Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, will report its fourth quarter 2013 financial results on March … moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring next, click here to view […]

Candy Crush mania coming to Wall Street

moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring next, click here to view […]